Logo image of NPTN

NeoPhotonics Corporation (NPTN) Stock Fundamental Analysis

USA - NYSE:NPTN - US64051T1007 - Common Stock

16.01 USD
+0.01 (+0.06%)
Last: 8/2/2022, 8:24:07 PM
16.01 USD
0 (0%)
After Hours: 8/2/2022, 8:24:07 PM
Fundamental Rating

2

Overall NPTN gets a fundamental rating of 2 out of 10. We evaluated NPTN against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. NPTN may be in some trouble as it scores bad on both profitability and health. NPTN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NPTN has reported negative net income.
NPTN Yearly Net Income VS EBIT VS OCF VS FCFNPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -10.28%
ROE N/A
ROIC -8.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPTN Yearly ROA, ROE, ROICNPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -5 -10 -15 -20 -25

1.3 Margins

Industry RankSector Rank
OM -7.62%
PM (TTM) -10.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NPTN Yearly Profit, Operating, Gross MarginsNPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTN is destroying value.
Compared to 1 year ago, NPTN has more shares outstanding
NPTN has a worse debt/assets ratio than last year.
NPTN Yearly Shares OutstandingNPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
NPTN Yearly Total Debt VS Total AssetsNPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

NPTN has an Altman-Z score of 2.22. This is not the best score and indicates that NPTN is in the grey zone with still only limited risk for bankruptcy at the moment.
NPTN has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC-0.84
WACC10.11%
NPTN Yearly LT Debt VS Equity VS FCFNPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

NPTN has a Current Ratio of 2.57. This indicates that NPTN is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.95 indicates that NPTN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.95
NPTN Yearly Current Assets VS Current LiabilitesNPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NPTN have decreased strongly by -1050.00% in the last year.
The Revenue has decreased by -4.80% in the past year.
The Revenue has been decreasing by -6.74% on average over the past years.
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%

3.2 Future

The Earnings Per Share is expected to grow by 72.02% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 20.89% on average over the next years. This is a very strong growth
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NPTN Yearly Revenue VS EstimatesNPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NPTN Yearly EPS VS EstimatesNPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NPTN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 20.00, which indicates a rather expensive current valuation of NPTN.
NPTN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 20
NPTN Price Earnings VS Forward Price EarningsNPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -266.15
NPTN Per share dataNPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

NPTN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NPTN's earnings are expected to grow with 77.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.65%
EPS Next 3Y77.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NPTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NeoPhotonics Corporation

NYSE:NPTN (8/2/2022, 8:24:07 PM)

After market: 16.01 0 (0%)

16.01

+0.01 (+0.06%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2022-08-05/amc
Earnings (Next)11-02 2022-11-02
Inst Owners1.01%
Inst Owner Change0%
Ins Owners18.64%
Ins Owner Change0%
Market Cap859.58M
Revenue(TTM)318.63M
Net Income(TTM)-33.33M
Analysts74.55
Price Target15.81 (-1.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB N/A
EV/EBITDA -266.15
EPS(TTM)-0.23
EYN/A
EPS(NY)0.8
Fwd EY5%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.93
BVpS2.82
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE N/A
ROCE N/A
ROIC -8.46%
ROICexc N/A
ROICexgc -8.53%
OM -7.62%
PM (TTM) -10.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 1.95
Altman-Z 2.22
F-Score1
WACC10.11%
ROIC/WACC-0.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NeoPhotonics Corporation / NPTN FAQ

What is the fundamental rating for NPTN stock?

ChartMill assigns a fundamental rating of 2 / 10 to NPTN.


What is the valuation status of NeoPhotonics Corporation (NPTN) stock?

ChartMill assigns a valuation rating of 3 / 10 to NeoPhotonics Corporation (NPTN). This can be considered as Overvalued.


How profitable is NeoPhotonics Corporation (NPTN) stock?

NeoPhotonics Corporation (NPTN) has a profitability rating of 0 / 10.